SPOTLIGHT: FDA gives nod to Ranbaxy's generic Diovan


India's Ranbaxy Laboratories got a tentative FDA OK for a generic version of the Novartis drug Diovan, used to treat high blood pressure and heart failure. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.